申请人:Phenex-FXR GmbH
公开号:US20200115357A1
公开(公告)日:2020-04-16
The present invention relates to sulfonamide-, sulfinamide- or sulfonimidamide containing compounds which bind to the liver X receptor (LXRa and/or LXRβ) and act preferably as inverse agonists of LXR.